Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Buckeye Technologies was a U.S.-based specialty materials company focused on cellulose-based products rather than a biotechnology, pharmaceutical, or healthcare therapeutic business. The company manufactured value-added cellulose specialty products, including absorbent materials, chemical cellulose, and customized paper products used in consumer, industrial, food, and pharmaceutical excipient applications. Its expertise centered on polymer chemistry, fiber science, and large-scale cellulose processing and manufacturing. Buckeye Technologies was acquired by Georgia-Pacific in 2013 for approximately $1.5 billion and no longer operates as an independent public company. Although some of its products had end-market exposure to hygiene and pharmaceutical formulation applications, the company itself was not a life sciences drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Buckeye Technologies.